Oncolytics Biotech Inc

ONCY chart

Oncolytics Biotech Inc news

• Oncolytics Biotech Inc

  Baystreet.ca · Oct 27, 10:45 AM EDT

• Stocks in play: Oncolytics Biotech Inc

  Yahoo! Finance Canada · Oct 27, 10:45 AM EDT

• Form 8K Oncolytics Biotech Inc. For: 27 October By Investing.com

  Investing.com Nigeria · Oct 27, 10:02 AM EDT

• Form 8-K ONCOLYTICS BIOTECH INC For: Oct 27

  StreetInsider · Oct 27, 9:46 AM EDT

• Oncolytics Biotech Reports Durable Responses in GOBLET Cohort 4 Anal Cancer Study and Advances Pelareorep Toward Registration

  Quiver Quantitative · Oct 27, 9:40 AM EDT

• Oncolytics Biotech Inc. (ONCY) stock price, news, quote and history

  Yahoo Finance Singapore · Oct 27, 9:31 AM EDT

• Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers

  Yahoo Finance · Oct 27, 9:30 AM EDT

• In an anal cancer study, every patient who responded to treatment survived beyond a year. Some lived past two years.

  Stock Titan · Oct 27, 9:30 AM EDT

• Oncolytics Biotech Inc. Estimates – NASDAQ:ONCY

  TradingView · Oct 24, 1:37 PM EDT

• Form 8K Oncolytics Biotech Inc. For: 20 October By Investing.com

  Investing.com Nigeria · Oct 20, 9:07 PM EDT

• Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer

  Yahoo Finance · Oct 20, 9:35 AM EDT

• Oncolytics Biotech® Provides Update on GOBLET Study Clinical Data and Final PanCAN Grant Payment

  Yahoo Finance · Oct 14, 9:30 AM EDT

Oncolytics Biotech Inc key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-10-27
• 8-K8-K2026-10-20
• 8-K8-K2026-10-14
• 8-K8-K2026-10-13
• DEF 14ADEF 14A2026-10-06
• 8-K8-K2026-09-29
• 8-K8-K2026-09-28
• 8-K8-K2026-09-10
• 8-K8-K2026-08-18
• 10-Q10-Q2026-08-12
• 8-K8-K2026-07-24
• 8-K8-K2026-07-20

About Oncolytics Biotech Inc

Ticker

ONCY (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

San Diego, CA

Incorporated in

NV

Fiscal year end

December 31

SEC CIK

1129928

Frequently asked questions